Sidney Kimmel Cancer Center

Thomas Jefferson University

Philadelphia, PA

Sorting 3 by

Accepting patients

A Phase Ib/II Study Evaluating Navitoclax After Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome
Learn more
  • BCL-2 Inhibitor
  • Phase 1/2

Accepting patients

Radiation-Based Reduced Intensity Conditioning

A 2 Step Approach to Haploidentical Transplant Using Radiation-Based Reduced Intensity Conditioning
Learn more
  • Allogeneic Stem Cell Transplant
  • Phase 2

Accepting patients

Partially Mismatched Stem Cell Transplant

Reduced Intensity, Partially HLA Mismatched Allogeneic BMT for Hematologic Malignancies Using Donors Other Than First-degree Relatives
Learn more
  • Allogeneic Stem Cell Transplant
  • Phase 1/2